J.P. Morgan: Biopharma Financial Outlook Is The Most Optimistic It’s Been Since 2022

Positive Views Rising Despite Minimal 2025 IPO Activity

 
• By Mandy Jackson
  
The biopharma financing outlook is truly optimistic for the first time in years (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business